Cargando…
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
• There is a concern that renin–angiotensin–aldosterone system (RAAS) blockers increase susceptibility to coronavirus 2019 (COVID-19). • There no evidence that treatment with RAAS blockers worsens the course of COVID-19. • Discontinuation of RAAS blockers may exacerbate cardiovascular comorbidities....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237918/ https://www.ncbi.nlm.nih.gov/pubmed/32834792 http://dx.doi.org/10.1016/j.nurpra.2020.05.007 |